After a decade of research and development, Amazentis is now ready to introduce Timeline. The revolutionary nutrition product is based on the company’s lead ingredient Mitopure which helps to curb age-associated cellular and muscular decline. Timeline will be available in the United States in the first half of 2020.
The ageing population is growing at an alarming rate. According to a 2019 Deutsche Bank study, there are more people above 65 than five for the first time. In its efforts to address the issues that come with old age, Amazentis, the Ecublens (VD) based startup pioneered the development of Mitopure, a highly pure form of Urolithin A, a bioactive dietary metabolite that is naturally produced when eating certain foods, such as the pomegranate. Mitopure promotes the health of mitochondria, the powerhouse of cells.
Following several years of rigorous research by leading scientists around the world, Amazentis is now introducing Timeline, the first consumer product in the world to contain precisely calibrated doses of Mitopure that have been clinically shown to improve the mitochondrial and cellular-health of the skeletal muscle. Timeline will be available to purchase online for consumers in the United States in the first half of 2020 at www.timelinenutrition.com.
“After a decade of research and trials to perfect Mitopure, we’re giving consumers access to a product that improves their muscle health by targeting ageing mitochondria,” said Amazentis CEO and Co-Founder, Chris Rinsch.
“For years, consumers have been searching for a solution to maintain muscle health as they age; Timeline provides a new way to proactively take control of cellular health early on, which directly impacts the ageing process,” added Amazentis Co-Founder and Chairman Patrick Aebischer.
Yesterday at the ongoing World Economic Forum in Davos, Rinsch had the opportunity to share the health benefits of Timeline and Mitopure with the audience.
(Press release/ran)
Please login or sign up to comment.
Commenting guidelines